↓ Skip to main content

Dove Medical Press

Article Metrics

Review of the safety, efficacy, and side effect profile of asenapine in the treatment of bipolar 1 disorder

Overview of attention for article published in Patient preference and adherence, July 2011
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
60 Mendeley
Title
Review of the safety, efficacy, and side effect profile of asenapine in the treatment of bipolar 1 disorder
Published in
Patient preference and adherence, July 2011
DOI 10.2147/ppa.s10968
Pubmed ID
Authors

Jodi Gonzalez, Thompson, Troy Moore

Abstract

Asenapine is approved for acute manic and mixed states in bipolar disorder. The objective is to review the efficacy of asenapine in bipolar disorder, with a particular focus on acceptability and adherence to treatment.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 2 3%
Spain 1 2%
Unknown 57 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 28%
Student > Bachelor 9 15%
Other 7 12%
Student > Postgraduate 6 10%
Student > Ph. D. Student 4 7%
Other 10 17%
Unknown 7 12%
Readers by discipline Count As %
Medicine and Dentistry 27 45%
Pharmacology, Toxicology and Pharmaceutical Science 4 7%
Agricultural and Biological Sciences 3 5%
Psychology 3 5%
Neuroscience 2 3%
Other 14 23%
Unknown 7 12%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 April 2013.
All research outputs
#6,845,652
of 11,442,636 outputs
Outputs from Patient preference and adherence
#488
of 929 outputs
Outputs of similar age
#63,748
of 121,770 outputs
Outputs of similar age from Patient preference and adherence
#12
of 20 outputs
Altmetric has tracked 11,442,636 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 929 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 121,770 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.